Growth Metrics

TherapeuticsMD (TXMD) Current Assets: 2010-2025

Historic Current Assets for TherapeuticsMD (TXMD) over the last 11 years, with Sep 2025 value amounting to $14.5 million.

  • TherapeuticsMD's Current Assets rose 19.33% to $14.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.5 million, marking a year-over-year increase of 19.33%. This contributed to the annual value of $12.3 million for FY2024, which is 3.93% up from last year.
  • According to the latest figures from Q3 2025, TherapeuticsMD's Current Assets is $14.5 million, which was up 7.74% from $13.5 million recorded in Q2 2025.
  • TherapeuticsMD's Current Assets' 5-year high stood at $187.0 million during Q1 2021, with a 5-year trough of $11.5 million in Q1 2024.
  • Over the past 3 years, TherapeuticsMD's median Current Assets value was $12.5 million (recorded in 2025), while the average stood at $14.7 million.
  • As far as peak fluctuations go, TherapeuticsMD's Current Assets surged by 30.65% in 2021, and later slumped by 80.11% in 2023.
  • TherapeuticsMD's Current Assets (Quarterly) stood at $119.5 million in 2021, then tumbled by 53.67% to $55.4 million in 2022, then plummeted by 78.69% to $11.8 million in 2023, then increased by 3.93% to $12.3 million in 2024, then climbed by 19.33% to $14.5 million in 2025.
  • Its last three reported values are $14.5 million in Q3 2025, $13.5 million for Q2 2025, and $12.5 million during Q1 2025.